Tag

Lupin Pharmaceuticals

All articles tagged with #lupin pharmaceuticals

FDA recalls millions of Lupin eye drops over possible contaminant
health1 month ago

FDA recalls millions of Lupin eye drops over possible contaminant

The FDA has recalled more than 2.5 million bottles of Lupin's prednisolone acetate eye drops due to a possible foreign substance; the substance and its entry method aren’t identified. The affected bottles (5 mL, 10 mL, 15 mL) are from India-based Lupin and are used to reduce inflammation after eye surgery or for allergies. Because this is a Class II recall (high risk), patients should not stop using the product on their own and should consult an eye doctor or pharmacist for guidance based on their condition.

Millions of Prednisolone Eye Drops Recalled for Contaminant Risk
health1 month ago

Millions of Prednisolone Eye Drops Recalled for Contaminant Risk

Lupin Pharmaceuticals is recalling more than 2.5 million prednisolone acetate eye drops in the U.S. due to a foreign substance; manufactured in India and sold in 5 mL, 10 mL, and 15 mL bottles with expiry dates from July 31, 2026 to March 31, 2028; the FDA class II recall indicates potential temporary health effects, though no injuries have been reported; Lupin did not immediately respond to questions, and the recall began in early June.

FDA recalls millions of Prednisolone eye drops over potential contaminant
health1 month ago

FDA recalls millions of Prednisolone eye drops over potential contaminant

The FDA is recalling more than 2.5 million bottles of Prednisolone Acetate Ophthalmic Suspension eye drops from Lupin Pharmaceuticals due to a possible foreign substance; the Class II recall indicates temporary or reversible health effects, and consumers should immediately stop using the recalled bottles and check the FDA enforcement report for affected lots.

"Tydemy Birth Control Recalled Over Efficacy Concerns"
health3 years ago

"Tydemy Birth Control Recalled Over Efficacy Concerns"

Lupin Pharmaceuticals is recalling two batches of the birth control pill Tydemy due to potential reduced effectiveness. The recall is being issued because the pills have decreased levels of ascorbic acid and high levels of a known impurity, which could impact the product's effectiveness and potentially result in unexpected pregnancies. The affected lots were distributed in the U.S. from June 2022 to May 2023, and patients are advised to contact their healthcare provider for advice on alternative treatments.